
Mojo is the UK's leading at-home sperm testing service, providing 97% accurate analysis and results within 48 hours. Their business model focuses on convenience and accessibility, allowing men to test and improve their sperm health from the comfort of home. Mojo offers various testing kits that analyze multiple biomarkers, including volume, count, concentration, and motility, with options for expert consultations. The company differentiates itself through its AI-powered analysis, partnerships with leading health institutions, and a commitment to affordability, making fertility testing accessible to a broader audience. With over 4,000 satisfied customers, Mojo is positioned as a market leader in home-to-lab sperm testing solutions.

Mojo is the UK's leading at-home sperm testing service, providing 97% accurate analysis and results within 48 hours. Their business model focuses on convenience and accessibility, allowing men to test and improve their sperm health from the comfort of home. Mojo offers various testing kits that analyze multiple biomarkers, including volume, count, concentration, and motility, with options for expert consultations. The company differentiates itself through its AI-powered analysis, partnerships with leading health institutions, and a commitment to affordability, making fertility testing accessible to a broader audience. With over 4,000 satisfied customers, Mojo is positioned as a market leader in home-to-lab sperm testing solutions.
Offering: CE-certified AI-powered at-home male fertility testing (semen analysis, sperm DNA fragmentation, clinician consultations)
Accuracy & Turnaround: Reported ~97% accuracy for AI analysis; semen analysis results typically within ~48 hours after lab receipt
Geography & HQ: Company referenced as UK-based in some materials and listed in records as Lyon, France
Team size (reported): ~6 employees (reported)
Funding (reported): Seed-stage fundraising reported; total funding figure reported as USD 5,540,000 with last funding date 2019-11-18 in one record
Male fertility diagnostics, at-home clinical testing, reproductive health
Healthtech / Fertility diagnostics
5540000.00 USD
Seed-stage funding listed; separate records reference additional seed announcements and participating investors in other entries